Criminal Justice Reform and Addiction Treatment Access

Nearly 65% of people in jail or prison meet criteria for a substance use disorder, yet fewer than 11% receive treatment during incarceration. That gap has devastating consequences: people with untreated addiction are four times more likely to return to incarceration within three years.

But a quiet transformation is reshaping how Virginia, Ohio, and Pennsylvania approach addiction in the criminal justice system. Drug courts now divert thousands from jail to treatment. Medication-assisted treatment (MAT) programs are expanding behind bars. And evidence-based policies are proving that treatment, not punishment, breaks the cycle of addiction and incarceration.

This shift isn't just compassionate — it's cost-effective. Every dollar spent on addiction treatment saves taxpayers $7 in reduced incarceration and healthcare costs. Here's how criminal justice reform is expanding treatment access and transforming lives across these three states.

What Are Drug Courts and How Do They Work?

Drug courts are specialized court programs that offer people facing criminal charges an alternative to traditional prosecution: complete a supervised treatment program instead of going to jail.

Here's how the process typically works:

Eligibility screening: Not everyone qualifies. Most drug courts focus on non-violent offenses and require participants to have a documented substance use disorder. Violent crimes and major trafficking charges usually disqualify someone.

Treatment-centered supervision: Participants enter intensive outpatient or residential treatment programs. They attend regular court check-ins (often weekly at first) where judges review their progress, order drug tests, and adjust requirements based on how they're doing.

Graduated sanctions and rewards: Miss an appointment or test positive? You might face increased supervision or brief jail stays. Meet milestones? Courts reduce check-in frequency, dismiss charges, or expunge records upon graduation.

Duration: Most programs last 12–24 months — long enough for treatment to take root, but structured to keep participants motivated.

The model works because it combines accountability with support. Instead of facing a judge once at sentencing, participants see the same judge regularly, building a relationship that recognizes their progress and holds them accountable when they slip.

According to the National Association of Drug Court Professionals, participants are 75% less likely to be arrested again compared to people who go through traditional prosecution. In Virginia alone, drug courts saved an estimated $12 million in 2025 by reducing incarceration and recidivism.

How Do Pre-Trial Diversion Programs Expand Treatment Access?

Pre-trial diversion programs intervene even earlier in the criminal justice process — before charges are formally filed or before trial begins. They're designed to keep people with addiction out of jail entirely while connecting them to treatment.

These programs work differently than drug courts:

Earlier intervention: Diversion can happen within days of arrest, preventing even short jail stays that disrupt employment, housing, and family stability.

Charges held or dismissed: Prosecutors agree to pause or drop charges if the person completes treatment and stays out of trouble for a set period (often 6–12 months).

Less court involvement: Participants typically check in with a case manager or probation officer instead of appearing regularly before a judge.

Broader eligibility: Some diversion programs accept people with more serious charges or prior records that would disqualify them from drug court.

In Ohio, the state's Pre-Trial Diversion Initiative expanded to 40 counties in 2025, diverting more than 3,000 people to treatment programs. Columbus and Cleveland reported 60% reductions in jail admissions for drug-related offenses after implementing robust diversion protocols.

Pennsylvania launched similar programs in Philadelphia and Pittsburgh, with a focus on connecting people to medication-assisted treatment like Suboxone immediately upon diversion. Early data shows participants who start MAT within 72 hours of arrest are twice as likely to complete their diversion program successfully.

These programs recognize a critical reality: jail doesn't treat addiction. In fact, incarceration often worsens outcomes by disconnecting people from community supports, jobs, and healthcare. Diversion programs break that cycle before it starts.

Is Medication-Assisted Treatment Available in Jails and Prisons?

For decades, most jails and prisons didn't allow medications like Suboxone (buprenorphine) or methadone, even though they're the gold standard for opioid use disorder treatment. People who were stable on MAT before arrest faced forced withdrawal — medically unnecessary, dangerous, and traumatic.

That's changing, though progress remains uneven:

Federal mandate for pregnant individuals: Since 2019, federal law requires jails to continue MAT for pregnant people who were already taking it before incarceration. Many states have expanded that protection to everyone.

Virginia's statewide jail MAT expansion: In 2024, Virginia began requiring all regional jails to offer buprenorphine to people diagnosed with opioid use disorder. By 2026, 85% of Virginia jails had active MAT programs, including facilities in Richmond, Norfolk, and Roanoke.

Ohio's pilot programs: Ohio launched MAT access in county jails across Cuyahoga County, Franklin County, and Hamilton County. Participants who continued MAT during incarceration were 60% less likely to overdose in the 90 days after release.

Pennsylvania's prison system: Pennsylvania's Department of Corrections expanded buprenorphine access to all state prisons in 2025, serving more than 2,000 individuals. County jails in Allegheny County and Philadelphia now offer both buprenorphine and methadone.

Access behind bars matters for two critical reasons:

First, it keeps people alive. Overdose risk spikes in the first two weeks after release, when tolerance has dropped but cravings remain intense. Continuing MAT through incarceration and into the community dramatically reduces that risk.

Second, it improves reentry success. People who stay on MAT during incarceration are more likely to find housing, maintain employment, and avoid re-arrest. Treatment continuity makes all the difference.

Not every facility offers MAT yet, though. If you or someone you care about is facing incarceration while on Suboxone, it's worth asking the facility about their MAT policies before admission. Public defenders and advocacy groups can sometimes intervene to ensure treatment continues.

How Do Post-Release Treatment Programs Prevent Relapse?

The period immediately following release from jail or prison is the most dangerous time for people with opioid use disorder. A 2023 study found that formerly incarcerated individuals are 129 times more likely to die from overdose in the first two weeks after release compared to the general population.

That's why post-release treatment linkage is critical. Here's how effective programs work:

In-reach before release: Case managers meet with people 30–60 days before their release date to arrange housing, connect them with treatment providers, and ensure they have insurance coverage (often Medicaid) activated on day one.

Medication starts inside: Ideally, people start or continue MAT while still incarcerated. That way, they leave with medication in their system and a prescription in hand, rather than facing a treatment gap.

Same-day or next-day appointments: The best programs schedule people for their first community treatment appointment within 24–72 hours of release. Telehealth options make this easier in rural areas where transportation is a barrier.

Wraparound support: Effective reentry programs don't just treat addiction. They help people navigate probation requirements, find stable housing, access mental health care, and rebuild family relationships.

Grata Health partners with reentry programs across Virginia, Ohio, and Pennsylvania to provide same-day telehealth appointments for people leaving incarceration. Most appointments happen within 48 hours of release, and we accept Medicaid and most private insurance plans that become active upon release.

One Pennsylvania reentry program reported a 70% reduction in overdose deaths among participants who started telehealth MAT within three days of release, compared to people who waited weeks for an in-person clinic appointment.

Getting started with online Suboxone treatment removes common barriers like transportation, childcare, and taking time off work — obstacles that often derail treatment in those critical early weeks of freedom.

What Does the Evidence Say About Treatment vs. Incarceration?

Decades of research show that addiction treatment reduces crime more effectively than incarceration alone — and at a fraction of the cost.

Here are the numbers:

Recidivism: People who receive MAT are 50–60% less likely to be re-arrested within three years compared to those who receive no treatment or abstinence-only programs.

Overdose deaths: MAT reduces overdose risk by 50–70% compared to detox alone or forced abstinence. Among people leaving incarceration, those who continue MAT have an 85% lower risk of fatal overdose in the first month after release.

Cost savings: Incarcerating someone costs taxpayers an average of $35,000 per year. Outpatient MAT costs about $5,000 per year. Even when including case management, drug testing, and counseling, treatment-focused approaches save money.

Employment: People in MAT programs are twice as likely to maintain steady employment compared to those who cycle through jail without treatment. Employment stability reduces recidivism and improves long-term recovery outcomes.

Child welfare: Parents in MAT programs are more likely to reunify with their children and maintain custody compared to those who face incarceration without treatment. Treatment and parenting aren't mutually exclusive — they reinforce each other.

The shift toward treatment-focused criminal justice reform isn't about being "soft on crime." It's about being smart: investing in what actually works to reduce harm, save lives, and rebuild communities.

How Are Opioid Settlement Funds Supporting These Programs?

Between 2021 and 2025, Virginia, Ohio, and Pennsylvania collectively received more than $2.1 billion from opioid litigation settlements with pharmaceutical companies. Much of that money is being directed toward expanding treatment access in the criminal justice system.

Here's how settlement funds are being used:

Drug court expansion: Ohio used $45 million to create 12 new drug courts and expand capacity in existing programs. Pennsylvania allocated $30 million to drug court infrastructure, including hiring specialized judges and case managers.

Jail-based MAT programs: Virginia invested $20 million in training correctional staff, purchasing medications, and hiring medical providers to deliver MAT in jails and prisons.

Reentry support: All three states funded pilot programs that provide housing vouchers, transportation assistance, and peer recovery coaching for people transitioning from incarceration to community treatment.

Telehealth infrastructure: Settlement funds supported grants to rural health systems and telehealth providers (like Grata Health) to ensure people in areas with few addiction specialists can access MAT via video visits.

To learn more about how these funds are being used in your state, see our article on opioid settlement funds and treatment access.

What Challenges Remain in Criminal Justice Reform?

Despite progress, significant barriers still limit treatment access in the criminal justice system:

Inconsistent MAT access: While some jails now offer buprenorphine, others still force people to withdraw. There's no federal requirement for universal MAT access in jails or prisons.

Stigma among correctional staff: Some officers and administrators still view MAT as "replacing one drug with another," leading to resistance or policy sabotage even when programs exist on paper.

Funding gaps: Drug courts and diversion programs rely heavily on grants that expire. Without sustained state funding, many programs close when initial money runs out.

Insurance activation delays: People leaving incarceration often face weeks-long delays in activating Medicaid coverage, creating a dangerous treatment gap. Some states have started pre-enrollment programs, but they're not universal.

Limited rural access: Counties with small populations often lack drug courts or specialized diversion programs. Telehealth helps, but internet access and device availability remain barriers.

Probation conflicts with treatment: Some probation officers still mandate abstinence-only programs or prohibit MAT, contradicting medical evidence and putting people at risk.

Advocates are pushing for federal legislation to guarantee MAT access in all correctional facilities, mandate Medicaid activation before release, and tie criminal justice funding to evidence-based treatment standards. Progress is slow but steady.

Does Treatment-Focused Justice Work for Everyone?

Drug courts and diversion programs aren't a perfect fit for every situation. Some people need higher levels of care than outpatient programs provide. Others face charges serious enough that public safety requires incarceration.

But the evidence is clear: for the majority of people with substance use disorders who come into contact with the criminal justice system, treatment works better than jail.

The key is meeting people where they are. That means offering different phases of treatment as people progress, recognizing that relapse is part of recovery, and designing systems that support long-term success rather than punishing setbacks.

If you're navigating the criminal justice system while managing opioid use disorder, know this: treatment is your right, not a privilege. Medication-assisted treatment like Suboxone is legal and protected by federal law, even during probation or parole. If someone tells you otherwise, seek legal advice from a public defender or advocacy organization.

And if you're ready to start treatment — whether you're currently incarcerated, recently released, or just worried about legal consequences of seeking help — know that getting treatment is always the right move. Courts, probation officers, and judges increasingly recognize MAT as legitimate medical care, not a legal liability.

Grata Health provides same-day telehealth appointments across Virginia, Ohio, and Pennsylvania. We accept most insurance, including Medicaid, and offer self-pay options for people without coverage. Your first visit can happen as soon as today.

Criminal justice reform and addiction treatment access aren't separate issues — they're two sides of the same effort to break cycles of harm and help people rebuild their lives. The evidence is clear, the programs are expanding, and the path forward is treatment, not incarceration.

Get started with online Suboxone treatment today and take the first step toward recovery, no matter where you're starting from.